Page last updated: 2024-08-25

eletriptan and almotriptan

eletriptan has been researched along with almotriptan in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's15 (78.95)29.6817
2010's3 (15.79)24.3611
2020's1 (5.26)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Deleu, D; Hanssens, Y1
Hashimoto, S; Iwata, M1
Marcus, DA1
Ferrari, MD; Goadsby, PJ; Lipton, RB; Roon, KI1
Freitag, FG1
Rapoport, AM; Sheftell, FD; Tepper, SJ1
Adelman, JU; Lewit, EJ1
Jähnichen, S; Pertz, HH; Radtke, OA1
Tfelt-Hansen, P1
Dodick, DW; Ferrari, MD; Goadsby, PJ; McCrory, DC; Williams, P1
Kowa, H; Nakashima, K; Takeshima, T1
Capuano, A; Di Trapani, G; Evangelista, M; Ferraro, D; Mei, D; Pierguidi, L; Vollono, C1
Autret-Leca, E; Beau-Salinas, F; Bensouda-Grimaldi, L; Cissoko, H; Jonville-Béra, AP1
Han, W; Li, M; Wang, J; Xu, H1
Amundsen, S; Fuskevåg, OM; Nordeng, H; Nordmo, E; Sager, G; Spigset, O1

Reviews

10 review(s) available for eletriptan and almotriptan

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
    Journal of clinical pharmacology, 2000, Volume: 40, Issue:7

    Topics: Acute Disease; Carbazoles; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines

2000
[Current topics: expectation for new triptans].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2001, Apr-10, Volume: 90, Issue:4

    Topics: Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2001
Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans).
    Archives of neurology, 2001, Volume: 58, Issue:7

    Topics: Analgesics, Non-Narcotic; Carbazoles; Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pain Measurement; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Triazoles; Tryptamines

2001
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Lancet (London, England), 2001, Nov-17, Volume: 358, Issue:9294

    Topics: Acute Disease; Administration, Oral; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Triazoles; Tryptamines

2001
Acute treatment of migraine and the role of triptans.
    Current neurology and neuroscience reports, 2001, Volume: 1, Issue:2

    Topics: Acute Disease; Blood Flow Velocity; Carbazoles; Clinical Trials as Topic; Drug Administration Routes; Female; Humans; Indoles; Male; Menstruation; Migraine Disorders; Oxazolidinones; Piperidines; Practice Guidelines as Topic; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents

2001
Mechanisms of action of the 5-HT1B/1D receptor agonists.
    Archives of neurology, 2002, Volume: 59, Issue:7

    Topics: Carbazoles; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2002
Comparative aspects of triptans in treating migraine.
    Clinical cornerstone, 2001, Volume: 4, Issue:3

    Topics: Carbazoles; Cardiovascular Diseases; Humans; Indoles; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines

2001
[Meta-analysis of triptan treatment in migraine].
    No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:9

    Topics: Carbazoles; Evidence-Based Medicine; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2004
Network meta-analysis of migraine disorder treatment by NSAIDs and triptans.
    The journal of headache and pain, 2016, Volume: 17, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Ibuprofen; Migraine Disorders; Oxazolidinones; Pyrrolidines; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines

2016

Trials

2 trial(s) available for eletriptan and almotriptan

ArticleYear
Meta-analysis of oral triptans.
    Cephalalgia : an international journal of headache, 2004, Volume: 24, Issue:8

    Topics: Administration, Oral; Clinical Trials as Topic; Humans; Indoles; Meta-Analysis as Topic; Pain; Pyrrolidines; Serotonin Receptor Agonists; Triazoles; Tryptamines

2004
Multiple attack study on the available triptans in Italy versus placebo.
    European journal of neurology, 2005, Volume: 12, Issue:7

    Topics: Adult; Female; Humans; Indoles; Italy; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines

2005

Other Studies

7 other study(ies) available for eletriptan and almotriptan

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
New medications show promise for migraine sufferers.
    Dentistry today, 2002, Volume: 21, Issue:10

    Topics: Botulinum Toxins, Type A; Carbazoles; Humans; Indoles; Magnesium; Migraine Disorders; Neuromuscular Agents; Phytotherapy; Plant Preparations; Pyrrolidines; Riboflavin; Serotonin Antagonists; Tanacetum parthenium; Tryptamines

2002
Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.
    Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 370, Issue:1

    Topics: Animals; Benzamides; Brain; Carbazoles; Dinoprost; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelium, Vascular; Female; Forecasting; Guinea Pigs; Iliac Artery; Indoles; Ketanserin; Male; Muscle Contraction; Muscle, Smooth; Oxadiazoles; Oxazolidinones; Piperazines; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Sumatriptan; Triazoles; Tryptamines

2004
TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management.
    Acta neurologica Scandinavica, 2004, Volume: 110, Issue:3

    Topics: Administration, Oral; Adult; Data Collection; Decision Support Techniques; Dose-Response Relationship, Drug; Female; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Patient Satisfaction; Patient Selection; Pyrrolidines; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines

2004
Drug dependence associated with triptans and ergot derivatives: a case/non-case study.
    European journal of clinical pharmacology, 2010, Volume: 66, Issue:4

    Topics: Claviceps; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Risk; Substance-Related Disorders; Sumatriptan; Tryptamines

2010
Transfer of triptans into human breast milk and estimation of infant drug exposure through breastfeeding.
    Basic & clinical pharmacology & toxicology, 2021, Volume: 128, Issue:6

    Topics: Adult; Breast Feeding; Female; Humans; Infant; Infant, Newborn; Migraine Disorders; Milk, Human; Oxazolidinones; Piperidines; Pyrrolidines; Triazoles; Tryptamines

2021